Manulife (Manufacturers Life Insurance)
EDIT icon

Manulife (Manufacturers Life Insurance)’s Editas Medicine EDIT Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$67.6K Sell
27,388
-976
-3% -$2.06K ﹤0.01% 2695
2025
Q4 		$58.1K Sell
28,364
-287
-1% -$829 ﹤0.01% 2792
2025
Q3 		$99.4K Sell
28,651
-880
-3% -$2.46K ﹤0.01% 2781
2025
Q2 		$65K Sell
29,531
-4,203
-12% -$6.88K ﹤0.01% 2846
2025
Q1 		$39.1K Buy
33,734
+669
+2% +$984 ﹤0.01% 2855
2024
Q4 		$42K Buy
33,065
+119
+0.4% +$303 ﹤0.01% 2943
2024
Q3 		$112K Sell
32,946
-653
-2% -$2.84K ﹤0.01% 2837
2024
Q2 		$157K Buy
33,599
+3,089
+10% +$17.4K ﹤0.01% 2695
2024
Q1 		$226K Sell
30,510
-1,031
-3% -$8.57K ﹤0.01% 2535
2023
Q4 		$320K Buy
31,541
+1,651
+6% +$14.5K ﹤0.01% 2382
2023
Q3 		$233K Buy
29,890
+1,816
+6% +$15.6K ﹤0.01% 2505
2023
Q2 		$231K Buy
28,074
+1,078
+4% +$9.39K ﹤0.01% 2527
2023
Q1 		$196K Hold
26,996
– – ﹤0.01% 2577
2022
Q4 		$239K Sell
26,996
-91
-0.3% -$999 ﹤0.01% 2443
2022
Q3 		$332K Sell
27,087
-680
-2% -$10.6K ﹤0.01% 2241
2022
Q2 		$328K Sell
27,767
-62
-0.2% -$831 ﹤0.01% 2337
2022
Q1 		$529K Sell
27,829
-6,764
-20% -$126K ﹤0.01% 2167
2021
Q4 		$918 Sell
34,593
-244
-0.7% -$8.4K ﹤0.01% 1890
2021
Q3 		$1.43M Sell
34,837
-3,387
-9% -$186K ﹤0.01% 1628
2021
Q2 		$2.17M Buy
38,224
+930
+2% +$34.4K ﹤0.01% 1578
2021
Q1 		$1.57M Sell
37,294
-149
-0.4% -$8.49K ﹤0.01% 1654
2020
Q4 		$2.63M Buy
37,443
+1,923
+5% +$79K ﹤0.01% 1435
2020
Q3 		$997K Buy
35,520
+2,447
+7% +$79.7K ﹤0.01% 1662
2020
Q2 		$970K Buy
33,073
+124
+0.4% +$3.24K ﹤0.01% 1634
2020
Q1 		$653K Buy
32,949
+2,889
+10% +$72.9K ﹤0.01% 1704
2019
Q4 		$890K Sell
30,060
-1,005
-3% -$25.1K ﹤0.01% 1737
2019
Q3 		$698K Sell
31,065
-31
-0.1% -$768 ﹤0.01% 1833
2019
Q2 		$769K Buy
31,096
+605
+2% +$14.4K ﹤0.01% 1790
2019
Q1 		$746K Buy
30,491
+1,327
+5% +$30K ﹤0.01% 1852
2018
Q4 		$664K Sell
29,164
-999
-3% -$27.2K ﹤0.01% 1808
2018
Q3 		$960K Sell
30,163
-3,895
-11% -$126K ﹤0.01% 1829
2018
Q2 		$1.22M Buy
34,058
+6,077
+22% +$215K ﹤0.01% 1757
2018
Q1 		$927K Buy
27,981
+1,102
+4% +$39.3K ﹤0.01% 1889
2017
Q4 		$826K Buy
26,879
+390
+1% +$9.82K ﹤0.01% 1976
2017
Q3 		$636K Sell
26,489
-348
-1% -$6.62K ﹤0.01% 2106
2017
Q2 		$450K Buy
26,837
+20,316
+312% +$366K ﹤0.01% 2372
2017
Q1 		$145K Buy
6,521
+3,944
+153% +$81.7K ﹤0.01% 3017
2016
Q4 		$42K Buy
2,577
+119
+5% +$1.81K ﹤0.01% 3458
2016
Q3 		$33K Sell
2,458
-2,446
-50% -$50.1K ﹤0.01% 3478
2016
Q2 		$120K Buy
+4,904
New +$165K ﹤0.01% 3129

Other funds holding EDIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s EDIT Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its Editas Medicine (EDIT) stake by 3.4% in Q1 2026, selling an estimated $2.06K and leaving 27,388 shares worth $67.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2695.

Manulife (Manufacturers Life Insurance) first reported a position in EDIT in Q2 2016 and has held it in 40 quarters since. The position peaked at $2.63M in Q4 2020. 208 funds tracked by Wall St. Rank hold EDIT as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 27,388 shares of Editas Medicine worth $67.6K as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) sold 976 Editas Medicine shares in Q1 2026, an estimated $2.06K.
  • Editas Medicine made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #2695 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Editas Medicine in Q2 2016 and has held it in 40 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Editas Medicine position peaked at $2.63M in Q4 2020.
  • 208 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.